Johns Hopkins-born stem cell startup Vita Therapeutics raises $20 million
Source: External source
A biotechnology company spun out of Johns Hopkins has raised $20 million to fuel its quest to create a new treatment for muscular dystrophy.
Posted February 18, 2021
About TEDCO
TEDCO, the Maryland Technology Development Corporation, enhances economic empowerment growth through the fostering of an inclusive entrepreneurial innovation ecosystem. TEDCO identifies, invests in, and helps grow technology and life science-based companies in Maryland. Learn more at www.tedcomd.com.
Media Contacts
Tammi Thomas, President, TEDCO, tthomas@tedcomd.com
Rachael Kalinyak, Associate Director, Marketing & Communications, TEDCO, rkalinyak@tedcomd.com